Aclaris Therapeutics (ACRS)

Aclaris Therapeutics (ACRS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ACRS last traded at $3.81, -4.03% on the day.
• Aclaris Therapeutics: market cap $615.29M, P/E -6.6, revenue $8.22M over the last four quarters, next earnings 2026-11-05.
• Over the past year ACRS returned 53.01%; year to date 26.58%.

Updated 2026-11-02 20:15 UTC